Agilent Technologies is a global provider of application-focused laboratory solutions for life sciences, diagnostics, and applied markets. It operates through three reportable segments: Life Sciences and Diagnostics Markets (instruments, reagents, software, and consumables for clinical and life sciences research, plus specialty contract development and manufacturing services for pharmaceutical customers); Agilent CrossLab (services, consumables, software, and laboratory automation spanning the entire lab workflow); and Applied Markets (instruments and software for identifying, quantifying, and analyzing the physical and biological properties of substances).
As of October 31, 2025, Agilent employed approximately 18,100 people worldwide. Products are sold primarily through direct sales, supplemented by distributors, resellers, manufacturers' representatives, and electronic commerce. Research, development, and manufacturing operations span multiple U.S. states and international locations including Australia, Canada, China, Denmark, Germany, Italy, Japan, Malaysia, Singapore, and the United Kingdom. Centralized order fulfillment and supply chain operations support all three business segments.
Agilent Cross Lab 42% · Life Sciences And Diagnostics Markets 39% · Applied Markets 19%
business segments · FY2025 (ended Oct 2025) · share of tagged segment revenue (10-K XBRL, as filed)
